Live from the NIH registry
Studies recruiting near Allentown right now
Top 25 of 234 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Diabetes Clinical Decision Support
Hyperglycemia, Hyperglycemia Stress
N/A
Interventional 15,732 participants sought
Penn State Health St. Joseph Medical Center — Reading, Pennsylvania (29.8 mi)
· Sponsor: Milton S. Hershey Medical Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: SWOG Cancer Research Network
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
PUSH-IT Continuing Enteral Feeds for Tracheostomy
Tracheostomy Complication, Critical Illness
N/A
Interventional 200 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: State University of New York at Buffalo
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
St. Lukes University Hospital /ID# 274362 — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: AbbVie
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Lehigh Valley Hospital - Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: American Society of Clinical Oncology
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
St. Luke's University Health Network ( Site 0017) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Project PEAK: Early Intervention for ADHD
Attention Deficit Hyperactivity Disorder, Parent-Child Relations
N/A
Interventional 180 participants sought
Lehigh University — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Lehigh University
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
Penn Medicine at Doylestown Health Cardiology — Doylestown, Pennsylvania (26.8 mi)
· Sponsor: Orchestra BioMed, Inc
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Lehigh Center for Clinical Research — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Syndeio Biosciences, Inc
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Medtronic
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Children's Oncology Group
A Fruit and Vegetable Prescription Program
Diabetes Mellitus, Diabetes Complications
N/A
Interventional 120 participants sought
Penn State Health St. Joseph Downtown Campus — Reading, Pennsylvania (29.8 mi)
· Sponsor: Milton S. Hershey Medical Center
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Triple Negative Breast Cancer, Non Small Cell Lung Cancer
Phase 2
Interventional 145 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Lehigh Valley Hospital — Allentown, Pennsylvania (1.1 mi)
· Sponsor: HistoSonics, Inc.
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Saint Luke's Cancer Center - Allentown — Allentown, Pennsylvania (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Sellersville, Pennsylvania (19.0 mi)
· Sponsor: Summit Therapeutics
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
Suicide and Depression, Adolescent Behavior
N/A
Interventional 900 participants sought
Berks Community Health Center — Reading, Pennsylvania (29.8 mi)
· Sponsor: University of Pittsburgh
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
Northeast Clinical Research Center — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Regeneron Pharmaceuticals